宠物疫苗市场报告：趋势、预测和竞争分析（至 2031 年）

全球宠物疫苗市场前景光明，在狗、猫和兔子等领域都存在应用机会。预计到 2031 年全球宠物疫苗市场规模将达到 112 亿美元，2025 年至 2031 年的复合年增长率为 6.1%。市场的主要驱动力是宠物数量的增加、饲主对宠物预防性医疗保健益处的认识不断提高以及政府对疫苗接种的监管。

• Lucintel 预测，由于伴同性动物越来越受欢迎、人们对动物健康重要性的认识不断提高以及宠物饲主生活方式的不断改变，犬类将继续成为疫苗接种类别中最大的份额。
• 根据应用，预计在预测期内狗的数量将出现最高增长。
• 由于政府对宠物接种疫苗以预防严重疾病的严格规定以及美国宠物拥有的增加，北美预计仍将是最大的地区。

宠物疫苗市场的策略性成长机会

由于对有效疫苗的需求不断增加以及对宠物预防性医疗保健的兴趣日益浓厚，宠物疫苗市场透过各种应用提供了多种策略性成长机会。以下是按应用程式分類的五个关键成长机会：

• 扩大常规免疫计划：增加常规免疫计划所涵盖的疫苗范围有可能刺激显着增长。这种方法可确保全面预防多种疾病，并鼓励更频繁地去看兽医，有助于整个宠物疫苗市场的成长。
• 针对异国风宠物的疫苗开发：针对异国风宠物（如爬虫类和鸟类）的疫苗开发潜力代表着策略性成长机会。市场扩张的动力源于异国风宠物拥有量的不断增加，以及针对其特定健康需求的疫苗需求的不断增加。
• 融入宠物健康计划：将疫苗接种融入综合宠物健康计划，透过促进预防性护理提供了策略性成长机会。这些计划包括定期检查和接种疫苗，以确保持续照顾您的宠物并减少疾病的发生。
• 增加流动兽医服务的可用性：流动兽医服务的可用性，特别是在农村和服务不足的社区，将改善获得疫苗的机会并创造成长机会。此类服务可以帮助饲主获得疫苗接种，从而提高疫苗接种水平。
• 宠物和旅游疫苗接种的增长：随着越来越多的饲主带着宠物旅行，对旅游相关疫苗接种的需求也增加。作为回应，开发和销售专为旅行宠物设计的疫苗代表着满足这一群体需求的策略性成长机会。

由于旨在提高疫苗接种率、改善疫苗接种机会和满足饲主多样化需求的有针对性的投资，宠物疫苗市场预计将实现显着增长。

宠物疫苗市场驱动因素与挑战

许多技术、经济和监管因素影响宠物疫苗市场的成长并带来挑战。疫苗的有效性将透过技术进步而提高，可负担性将受到经济因素的影响，市场动态将受到监管障碍的影响。因此，了解这些市场驱动因素和挑战对于驾驭市场和确定成长和创新领域至关重要。

推动宠物疫苗市场发展的因素有：

• 宠物主人数量不断增加：全球宠物主人数量的不断增加推动了宠物疫苗的需求。随着越来越多的家庭饲养宠物，对疫苗接种以预防常见疾病的需求也日益增长。这一趋势正在支持市场扩张并鼓励开发新的疫苗产品以满足多样化的健康需求。
• 疫苗技术的进步：疫苗技术的创新，包括更有效、更安全的配方，是市场成长的主要动力。 mRNA 疫苗和改进的输送系统等新兴技术将提高疫苗的有效性和安全性，扩大市场潜力并应对伴侣动物新出现的健康威胁。
• 提高对宠物健康的认识：饲主对疫苗接种重要性的认识不断提高，这推动了市场需求。随着宠物饲主对疫苗接种的好处了解得越来越多，他们将更有可能遵守疫苗接种计划，从而提高市场渗透率并改善宠物的整体健康状况。
• 政府和监管支持：政府和监管机构的支持，例如疫苗宣传活动和津贴，将推动市场成长。这些努力确保疫苗安全、有效、价格合理，进而提高宠物的疫苗接种水准。
• 扩大兽医服务：扩大兽医服务，包括新诊所和流动单位，将改善宠物接种疫苗的机会。可近性的提高可提高疫苗接种率，扩大市场覆盖范围至服务不足的地区，并提供全面的宠物照护。

宠物疫苗市场面临的挑战是：

• 疫苗开发成本高：开发和生产疫苗的高成本可能会限制疫苗的可负担性和可用性。这项挑战使得低收入宠物饲主难以负担疫苗接种费用，导致平均宠物拥有率下降，进而影响市场成长。
• 监管障碍：满足疫苗审批的复杂监管要求将是一项挑战。这些障碍推迟了新疫苗的推出，增加了开发成本，影响了市场动态，并减缓了创新的步伐。
• 农村地区的认知有限：农村地区对宠物疫苗接种重要性的认识较低可能会阻碍市场的成长。这些地区的低疫苗接种覆盖率对全面疾病控制构成挑战并影响整体市场吸收，凸显了有针对性的教育和推广活动的必要性。

宠物拥有率上升、疫苗技术的进步以及对宠物健康意识的提高等市场驱动因素正在塑造宠物疫苗市场并推动其成长。然而，开发成本高、监管障碍以及农村地区认知度低等挑战构成了重大障碍。利用市场驱动力和克服挑战对于推动市场发展和确保广泛获得有效的宠物疫苗至关重要。

目录

第一章执行摘要

第 2 章。

• 简介、背景和分类
• 供应链
• 产业驱动因素与挑战

第 3 章 市场趋势与预测分析（2019-2031）

• 宏观经济趋势（2019-2024）与预测（2025-2031）
• 全球宠物疫苗市场趋势（2019-2024 年）及预测（2025-2031 年）
• 全球宠物疫苗市场类型
  • 犬科动物
  • 猫科
• 全球宠物疫苗市场（按疫苗接种类型）
  • 狗家族
  • 核心疫苗
  • 非核心疫苗
• 全球宠物疫苗市场（依给药途径）
  • 注射疫苗
  • 鼻腔内疫苗
• 全球宠物疫苗市场（按应用）
  • 狗
  • 猫
  • 兔子
  • 其他的

第 4 章区域市场趋势与预测分析（2019-2031 年）

• 全球宠物疫苗市场（按地区）
• 北美宠物疫苗市场
• 欧洲宠物疫苗市场
• 亚太宠物疫苗市场
• 世界其他地区宠物疫苗市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球宠物疫苗市场成长机会（按类型）
  • 全球宠物疫苗市场成长机会（按疫苗接种类型）
  • 全球宠物疫苗市场按给药途径分類的成长机会
  • 全球宠物疫苗市场成长机会（按应用）
  • 全球宠物疫苗市场各区域成长机会
• 全球宠物疫苗市场的新趋势
• 战略分析
  • 新产品开发
  • 全球宠物疫苗市场产能扩张
  • 全球宠物疫苗市场的企业合併
  • 认证和许可

第七章主要企业简介

• Elanco
• Merck
• Ceva
• Virbac
• Zoetis
• HIPRA
• Merial

The future of the global pet vaccine market looks promising with opportunities in the dog, cat, and rabbit applications. The global pet vaccine market is expected to reach an estimated $11.2 billion by 2031 with a CAGR of 6.1% from 2025 to 2031. The major drivers for this market are the increasing adoption of pet animals, growing awareness among pet owners about the benefits of preventive healthcare for their pets, and government regulations regarding vaccinations.

• Lucintel forecasts that, within the vaccination category, the canine family will remain the largest segment due to the rising popularity of companion animals, growing awareness of the importance of animal health, and the evolving lifestyles of pet owners.
• Within the application category, dog is expected to witness the highest growth over the forecast period.
• In terms of regions, North America will remain the largest region due to strict government regulations regarding vaccinations to protect pets from serious diseases and the rising adoption of pets in the USA.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Pet Vaccine Market

Emerging trends are reshaping the future of the pet vaccine market as it undergoes significant transformation. Developments in pet ownership patterns, technological innovations, and the increasing focus on preventive healthcare have been key drivers of these trends. The following are five major trends that are influencing the pet vaccine market.

• Personalized Pet Vaccination Plans: Personalized pet vaccination plans have become a popular trend among veterinarians who now offer customized vaccination schedules based on individual pet needs. This approach ensures that vaccines given to pets are appropriate, thereby reducing instances of over-vaccination and improving the overall health of pets. With personalized plans becoming increasingly common, pet owners looking for tailored care for their animals represent yet another example of this wider tendency toward humanizing these companions.
• Growth of Combination Vaccines: In the pet vaccine market, there is increased usage of combination vaccines, which protect against multiple diseases through a single shot. These vaccines save time and reduce anxiety levels for both pets and people because fewer vet visits are needed. Cost-effectiveness, along with rising awareness about overall wellness for pets, has led to increased demand for combination vaccines compared with other types available in many areas.
• Advances in Vaccine Technology: There is development of new vaccine formulations, including DNA and mRNA vaccines, aimed at providing better protection with reduced side effects within the pet vaccine market due to technological advancements in vaccine development. They would result in more effective vaccines that can be manufactured and delivered more efficiently to satisfy the growing global demand for high-quality pet vaccines.
• Increased Focus on Preventive Healthcare: There is a growing emphasis on preventive healthcare in the pet vaccine market, with regular vaccinations becoming increasingly important as part of routine care by pet owners. This trend is supported by veterinary professionals who advocate for proactive health management to prevent disease onset. As preventive care becomes mainstream, it will likely boost the demand for vaccinations and related health services.
• Expansion of Veterinary Services: Opening new clinics and mobile veterinary units plays a major role in expanding access to pet vaccines, especially in rural and underserved regions. The result of this trend is that vaccination rates have increased, leading to improved overall health among pets. Veterinary services will likely be pivotal in supporting the growth of the pet vaccine market as it continues to expand.

These emerging trends are reshaping the pet vaccine market by driving innovation, enhancing access to vaccines, and improving the overall standard of pet healthcare. As these trends continue to evolve, they will contribute to a more robust and dynamic market, better equipped to meet the needs of pet owners and their animals.

Recent Developments in the Pet Vaccine Market

The market for pet vaccines has undergone several developments that improve vaccine effectiveness, accessibility, and adoption. These improvements are crucial in responding to the increasing need for comprehensive pet healthcare. Below are five key developments that are significantly influencing the market.

• Introduction of Modern Vaccines: Recent developments include the introduction of modern vaccines that offer immunity against targeted diseases and have limited side effects. The new vaccines help protect against newly emerging infections among animals, raising vaccination rates and leading to better health outcomes among pets.
• Expansion of Global Vaccine Manufacturing: The expansion of global vaccine manufacturing capabilities is improving supply chain efficiency and accessibility of vaccines in different regions. This is vital since it helps meet the demand for pet vaccines in new markets by ensuring the continued supply of quality vaccines.
• Regulatory Approvals for New Vaccines: Regulatory authorities in some countries have approved specific pet vaccines related to novel diseases, reflecting the increasing emphasis on preventing diseases rather than curing them after they attack pets. This allows more specialized vaccines to be introduced, covering various needs of pets in different locations.
• Growth in Pet Insurance Coverage: The growth of pet insurance coverage, including vaccination costs, encourages more pet owners to vaccinate their pets. Higher vaccination rates and a wider range of vaccine requirements drive growth within the overall pet vaccine market.
• Collaboration Between Veterinary Professionals and Pharma Companies: Collaboration between veterinary professionals and pharmaceutical firms results in stronger vaccine development as well as improved vaccination protocols. Such alliances play an important role in promoting innovation and adapting vaccines according to the changing needs experienced by domestic animals and their owners.

These recent advancements significantly impact the pet vaccine market through improved efficiency and increased access levels, while accelerating the adoption rate. Generally, all these changes favor a more flexible pet vaccine industry that can address health issues affecting animals worldwide.

Strategic Growth Opportunities for Pet Vaccine Market

The pet vaccine market provides several strategic growth opportunities throughout various applications, driven by increasing demand for effective vaccines and a growing focus on preventive pet healthcare. Here are five major growth opportunities by application.

• Expanding Routine Vaccination Programs: Broadening the range of vaccines covered under routine vaccination programs has the potential to spur significant growth. This approach ensures comprehensive protection from multiple diseases and stimulates frequent visits to vets, thereby supporting overall pet vaccine market expansion.
• Developing Specialized Vaccines for Exotic Pets: The possibility of developing vaccines specifically for exotic pets, like reptiles and birds, represents a strategic growth opportunity. Market expansion is driven by the increasing ownership of exotic pets, while the demand for their specific health needs rises for vaccines.
• Integration with Pet Wellness Programs: Incorporating vaccines into comprehensive pet wellness programs provides a strategic growth opportunity through the promotion of preventive care. These programs include regular check-ups and vaccinations, guaranteeing consistent care for pets and reducing disease outbreaks.
• Increasing Availability of Mobile Veterinary Services: The availability of mobile veterinary services, particularly in rural areas or underserved communities, can enhance access to vaccines, creating an opportunity for growth. These services reach pet owners who cannot easily find traditional veterinary clinics, thus increasing vaccination levels.
• Growth in Pet Travel Vaccinations: The number of pet owners traveling with their animals has increased, resulting in increased demand for travel-related vaccinations. In response, developing and marketing vaccines specifically designed for traveling pets presents a strategic growth opportunity that serves the needs of this population.

The pet vaccine market is poised for significant growth acceleration due to targeted investments aimed at boosting vaccine coverage, improving access, and meeting the varied requirements of pet owners.

Pet Vaccine Market Driver and Challenges

Numerous technological, economic, and regulatory factors influence the growth of the pet vaccine market and present challenges. Vaccine efficacy is improved by technological advancements; affordability is affected by economic factors, and market dynamics are shaped by regulatory obstacles. Thus, understanding these drivers and challenges is critical to successfully navigating the market and identifying areas for growth and innovation.

The factors driving the pet vaccine market include:

• Rising Pet Ownership: The increasing number of pet owners globally drives demand for pet vaccines. As more households adopt pets, the need for vaccines to prevent common diseases grows. This trend supports market expansion and encourages the development of new vaccine products to address diverse health needs.
• Advances in Vaccine Technology: Innovations in vaccine technology, including more effective and safer formulations, are significant drivers of market growth. Advanced technologies, such as mRNA vaccines and improved delivery systems, enhance vaccine efficacy and safety, expanding market potential and addressing emerging health threats in pets.
• Growing Awareness of Pet Health: Increased awareness among pet owners about the importance of vaccinations drives market demand. As pet owners become more informed about the benefits of vaccines, they are more likely to adhere to vaccination schedules, leading to higher market adoption rates and better overall pet health.
• Government and Regulatory Support: Support from governments and regulatory bodies, including vaccination campaigns and subsidies, promotes market growth. These initiatives ensure vaccine safety and efficacy, making them accessible at reasonable prices and thereby raising vaccination levels among pets.
• Expansion of Veterinary Services: The growth of veterinary services, including new clinics and mobile units, enhances access to pet vaccines. Improved accessibility leads to higher vaccination rates, supporting market expansion to reach underserved areas and providing comprehensive pet healthcare.

Challenges in the pet vaccine market include:

• High Cost of Vaccine Development: The high cost associated with developing and producing vaccines can limit affordability and accessibility. This challenge affects market growth by making it difficult for low-income pet owners to afford them, resulting in a decrease in average ownership rates.
• Regulatory Hurdles: Navigating complex regulatory requirements for vaccine approval poses a challenge. These hurdles can delay the introduction of new vaccines and increase development costs, affecting market dynamics and slowing the pace of innovation.
• Limited Awareness in Rural Areas: Limited awareness about the importance of pet vaccinations in rural areas can hinder market growth. Low vaccination rates in these regions challenge comprehensive disease control and impact overall market adoption, highlighting the need for targeted education and outreach efforts.

Drivers such as rising pet ownership, advances in vaccine technology, and increased awareness of pet health shape the pet vaccine market and promote its growth. Nonetheless, challenges like high development costs, regulatory hurdles, and limited awareness in rural areas are substantial barriers. Addressing these challenges while leveraging growth drivers will be essential for advancing the market and ensuring broader access to effective pet vaccines.

List of Pet Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pet vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pet vaccine companies profiled in this report include-

• Elanco
• Merck
• Ceva
• Virbac
• Zoetis
• HIPRA
• Merial

Pet Vaccine by Segment

The study includes a forecast for the global pet vaccine market by type, vaccination, mode of administration, application, and region.

Pet Vaccine Market by Type [Analysis by Value from 2019 to 2031]:

• Canlane
• Feline

Pet Vaccine Market by Vaccination [Analysis by Value from 2019 to 2031]:

• Canine Family
• Core Vaccines
• Non-Core Vaccines

Pet Vaccine Market by Mode of Administration [Analysis by Value from 2019 to 2031]:

• Injectable Vaccines
• Intranasal Vaccines

Pet Vaccine Market by Application [Analysis by Value from 2019 to 2031]:

• Dogs
• Cats
• Rabbits
• Others

Pet Vaccine Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Pet Vaccine Market

The global market for pet vaccines has seen major developments in different regions due to the rise of pet ownership, awareness of pet health, and innovations made in vaccine technology. These changes help to meet the increasing need for effective vaccines that ensure pets are healthy worldwide. Here are some of the most important developments in the pet vaccine market across the United States, China, Germany, India, and Japan.

• USA: The US pet vaccine market has seen a remarkable upswing due to the emerging trend of anthropomorphism regarding pets. Recent developments include the launch of advanced vaccines that target emerging pet diseases and an increased number of veterinary practices providing custom vaccination plans. Furthermore, partnerships between biotech corporations and schools have resulted in better vaccine formulations, making pet vaccines more effective and secure.
• China: The Chinese pet vaccine market is growing rapidly as the urban population continues to adopt pets. Additionally, new regulations concerning vaccinations have been implemented by the government, propelling growth in this industry. Key highlights include the authorization of new domestically manufactured vaccines and partnerships between local firms and international companies aimed at improving quality and distribution systems, leading to an increasing demand for pet healthcare products.
• Germany: Germany's pet vaccine market thrives on research and development. Recent developments include the introduction of vaccines targeting exotic pets and an increased emphasis on preventive care measures. Moreover, significant investment has been made toward creating a robust animal health infrastructure; for example, there has been an expansion of veterinary clinics and specialist pet hospitals, allowing larger numbers to be vaccinated against various disease-causing agents and maintaining better overall health among animals.
• India: Rising middle-class households adopting pets, together with increasing awareness about pet health, have spurred growth within India's pet vaccine marketplace. Developments here include low-cost vaccine alternatives focusing on common ailments affecting domestic animals, combined with government initiatives aimed at creating awareness about available options for protecting pets against diseases through vaccination campaigns. Additionally, the entry of global veterinary pharmaceutical companies into the Indian market has increased the reliable supply of good-quality vaccines.
• Japan: The Japanese pet vaccine market is characterized by an increasing embrace of advanced vaccine techniques and personalized pet healthcare. Recent developments include the adoption of new vaccine delivery systems, such as oral vaccines that simplify administration. In addition, there has been a growing trend for pet wellness programs with comprehensive vaccination plans, indicating an appreciation of preventive healthcare among pet owners.

Features of the Global Pet Vaccine Market

Market Size Estimates: Pet vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Pet vaccine market size by various segments, such as by type, vaccination, mode of administration, application, and region in terms of ($B).

Regional Analysis: Pet vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, vaccinations, mode of administrations, applications, and regions for the pet vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pet vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the pet vaccine market by type (canlane and feline), vaccination (canine family, core vaccines, and non-core vaccines), mode of administration (injectable vaccines and intranasal vaccines), application (dogs, cats, rabbits, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pet Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Pet Vaccine Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Pet Vaccine Market by Type
  • 3.3.1: Canlane
  • 3.3.2: Feline
• 3.4: Global Pet Vaccine Market by Vaccination
  • 3.4.1: Canine Family
  • 3.4.2: Core Vaccines
  • 3.4.3: Non-Core Vaccines
• 3.5: Global Pet Vaccine Market by Mode of Administration
  • 3.5.1: Injectable Vaccines
  • 3.5.2: Intranasal Vaccines
• 3.6: Global Pet Vaccine Market by Application
  • 3.6.1: Dogs
  • 3.6.2: Cats
  • 3.6.3: Rabbits
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Pet Vaccine Market by Region
• 4.2: North American Pet Vaccine Market
  • 4.2.1: North American Market by Vaccination: Canine Family, Core Vaccines, and Non-Core Vaccines
  • 4.2.2: North American Market by Application: Dogs, Cats, Rabbits, and Others
• 4.3: European Pet Vaccine Market
  • 4.3.1: European Market by Vaccination: Canine Family, Core Vaccines, and Non-Core Vaccines
  • 4.3.2: European Market by Application: Dogs, Cats, Rabbits, and Others
• 4.4: APAC Pet Vaccine Market
  • 4.4.1: APAC Market by Vaccination: Canine Family, Core Vaccines, and Non-Core Vaccines
  • 4.4.2: APAC Market by Application: Dogs, Cats, Rabbits, and Others
• 4.5: ROW Pet Vaccine Market
  • 4.5.1: ROW Market by Vaccination: Canine Family, Core Vaccines, and Non-Core Vaccines
  • 4.5.2: ROW Market by Application: Dogs, Cats, Rabbits, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Pet Vaccine Market by Type
  • 6.1.2: Growth Opportunities for the Global Pet Vaccine Market by Vaccination
  • 6.1.3: Growth Opportunities for the Global Pet Vaccine Market by Mode of Administration
  • 6.1.4: Growth Opportunities for the Global Pet Vaccine Market by Application
  • 6.1.5: Growth Opportunities for the Global Pet Vaccine Market by Region
• 6.2: Emerging Trends in the Global Pet Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Pet Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pet Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Elanco
• 7.2: Merck
• 7.3: Ceva
• 7.4: Virbac
• 7.5: Zoetis
• 7.6: HIPRA
• 7.7: Merial